Cargando…
Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series
Hypertension impacts overall prognosis in cancer patients. There are no specific recommendations for its management in these patients. We report a case series of 5 cancer patients with suboptimal BP lowering and even worsening BP with ACEi or ARBs that improved to normal upon discontinuation of thes...
Autores principales: | Goel, Mishita, Varandani, Rajiv Sunil, Okwuosa, Tochukwu M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450561/ https://www.ncbi.nlm.nih.gov/pubmed/32864163 http://dx.doi.org/10.1186/s40959-020-00071-x |
Ejemplares similares
-
Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
por: Zimmermann, Tobias, et al.
Publicado: (2021) -
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system
por: Viazzi, Francesca, et al.
Publicado: (2013) -
Baseline Electrocardiographic Abnormalities in Pre-Treatment Cancer Compared With Non-Cancer Patients: A Propensity Score Analysis
por: Golemi, Lolita, et al.
Publicado: (2023) -
Management of renin-angiotensin-aldosterone inhibitors and other antihypertensives and their clinical effects on pre-anesthesia blood pressure
por: Balcı, Eda, et al.
Publicado: (2022) -
Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report
por: Sabbadin, Chiara, et al.
Publicado: (2022)